SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-605974
Filing Date
2016-05-27
Accepted
2016-05-27 14:14:09
Documents
2
Group Members
BAY CITY CAPITAL COOPERATIEF U.A.BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND V, L.P.BAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d203152dsc13d.htm SC 13D 116985
2 EX-99.1 d203152dex991.htm EX-99.1 2385
  Complete submission text file 0001193125-16-605974.txt   121238
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address PADUALAAN 8 POSTVAK 133 UTRECHT P7 3584 CH
Business Address PADUALAAN 8 POSTVAK 133 UTRECHT P7 3584 CH 31 030 253 8800
Merus N.V. (Subject) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89510 | Film No.: 161681678
SIC: 2834 Pharmaceutical Preparations